A retrospective study assessing the outcomes of inotuzumab ozogamicin in relapsed/refractory adult extramedullary involvement of B-cell acute lymphoblastic leukemia patients
Latest Information Update: 02 Aug 2021
At a glance
- Drugs Inotuzumab ozogamicin (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Expanded access; Therapeutic Use
- 02 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association